Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-10, Stock:PFE, The news for the past five days is as follows:
2019-10-03: NEWS1: US Indexes Close Higher Thursday.NEWS2: Dow Jones Today: A Rebound With an Asterisk.NEWS3: Here is the 8th Most Popular Stock Among Hedge Funds.NEWS4: Pres. Trump to expand private Medicare Advantage program.NEWS5: Merck's Pediatric Filings for Dificid Get FDA's Priority Review.NEWS6: The Zacks Analyst Blog Highlights: Pfizer, DISH Network, Micron Technology, Walt Disney and C.H. Robinson.
2019-10-04: NEWS1: Pharma Stock Roundup: JNJ's Opioid Settlement, FDA Updates for AZN, GSK, MRK, RHHBY.NEWS2: J&J Gets Breakthrough Therapy Tag for Prostate Cancer Drug.
2019-10-07: NEWS1: How A Deal With Pfizer Sent This Pharma Stock Rocketing In High Volume.NEWS2: Calithera (CALA) Completes Enrollment in Mid-Stage RCC Study.NEWS3: Zoetis Appoints Kristin Peck as New CEO, Alaix to Retire.NEWS4: Akcea Stocks Soars on Pfizer Licensing Agreement.NEWS5: Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx).
2019-10-08: NEWS1: Pfizer (PFE) Stock Moves -1.1%: What You Should Know.NEWS2: Were Hedge Funds Right About Souring on Pfizer?.NEWS3: 5 Underperforming Guru Stocks.NEWS4: Is Pfizer (NYSE:PFE) A Risky Investment?.NEWS5: REFILE-UPDATE 1-Humira, Rituxan top list of U.S. drugs with biggest price increases -report.NEWS6: REFILE-Humira, Rituxan top list of U.S. costliest drug price increases -report.
2019-10-09: NEWS1: Clovis (CLVS) Shares Drop on Goldman Sachs' Bearish Outlook.NEWS2: Biotech Stock Roundup: GILD's Descovy Label Expansion Gets FDA Nod & Other Updates.NEWS3: Nektar's Shares Drop on Rating Downgrade by Goldman Sachs.

Answer: Rise